An aggressive insulin titration pattern is associated with better glycemic control during short‐term intensive insulin therapy
Аннотация
ABSTRACT Aim To investigate the associations between insulin titration patterns and glycemic outcomes in continuous subcutaneous insulin infusion (CSII)‐based short‐term intensive insulin therapy (IIT). Materials and Methods Medical records of newly diagnosed type 2 diabetes (2001–2022) were stratified by time to achieve maximum dose ( T max ) into ascending/descending groups, with the latter split into aggressive/non‐aggressive cohorts by median T max , to compare glucose‐derived time in range (dTIR; 3.9–10.0 mmol/L), time below range (dTBR1; <3.9 mmol/L), post‐therapy fasting glucose (FG), and to identify predictors of FG <6.1 mmol/L. Results A total of 1,916 patients were stratified into ascending ( n = 514) or descending ( n = 1,402) groups, and aggressive ( n = 681) or non‐aggressive ( n = 721) cohorts. dTIR was highest in the aggressive group, followed by the non‐aggressive and ascending groups (89.7% [84.5, 93.6], 85.7% [79.6, 90.8], 76.2% [64.3, 84.9], respectively). Compared with the non‐aggressive group, the aggressive group had a 1.73‐percentage‐point higher dTIR after adjustment (95% CI 0.91–2.56; P < 0.001), lower glucose variability, lower maximum and pump‐suspension insulin doses, greater dose reduction, and shorter CSII treatment and hospitalization, with similar dTBR1 and post‐therapy FG (6.1 ± 1.2 vs. 6.3 ± 1.2 mmol/L, P = 0.056). Predictors of post‐therapy FG <6.1 mmol/L included higher BMI, greater dTIR and dTBR1 in both trajectory groups; younger age, lower HbA1c, longer CSII duration, and lower final insulin dose in the descending group. Conclusions An aggressive titration pattern was associated with better glycemic control without increasing detected hypoglycemia relative to the non‐aggressive pattern, suggesting a potential benefit of timely insulin titration that requires prospective evaluation.